Cargando…
Understanding the Elevated Lethality of COVID-19 in Liver Transplant Recipients: Does Immunosuppression Management Matter? Results from a Brazilian Multicentric Historical Cohort
BACKGROUND: Infections by SARS-CoV-2 in liver transplant recipients (LT) patients are of particular concern, notably due to perceived added risks related to immunosuppression and comorbidity burden. Current literature on this topic often relies on small, non-standardized, and geographically limited...
Autores principales: | Boin, Ilka Fsf, Riccetto, Eduardo, Genzini, Tercio, Santos, Regina Gomes, Moreira, Lucio Figueira Pacheco, Pinto, Laura Cristina Machado, Garcia, Jose Huygens Parente, Stucchi, Raquel Sb, Perales, Simone Reges, Zanaga, Leticia, Da Silva, Renato Fereira, Da Silva, Rita Cm Fereira, Haddad, Luciana, Ac D´Albuquerque, Luiz, Dealmeida, Marcio Dias, Watanabe, Andre, Peixoto, Gustavo S, De Melo, Claudio Moura Lacerda, Bezerra, Renata Ferreira, Tefilli, Nertan Luiz, Halpern, Marcia, Godoy, Maira Silva, Nogara, Marcelo, Mancero, Jorge Marcelo Padilla, Noujaim, Huda Maria, Rangel, Erika Bevilaqua, Ataide, Elaine Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201326/ https://www.ncbi.nlm.nih.gov/pubmed/37330340 http://dx.doi.org/10.1016/j.transproceed.2023.05.007 |
Ejemplares similares
-
Incidence and Impact of COVID-19 Cases in Brazilian Liver Transplant Recipients: An Academic, Single-center Experience
por: Riccetto, Eduardo, et al.
Publicado: (2022) -
Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center
por: Zanaga, L.P., et al.
Publicado: (2019) -
Renal autotransplantation to treat renal artery aneurysm: case report
por: Genzini, Tercio, et al.
Publicado: (2014) -
BAR, SOFT AND DRI POST-HEPATIC TRANSPLANTATION: WHAT IS THE BEST FOR SURVIVAL ANALYSIS?
por: TORTEROLLI, Fernando, et al.
Publicado: (2021) -
Survival benefits of interferon-based therapy in patients with recurrent
hepatitis C after orthotopic liver transplantation
por: Zanaga, L.P., et al.
Publicado: (2017)